Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicity

Erika N Scott1,2, Galen E B Wright1,2, Britt I Drögemöller2,3

  • 1Faculty of Medicine, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.

Insights

Decreased GDF5 gene expression is linked to anthracycline-induced cardiotoxicity (ACT), a severe chemotherapy side effect. This finding, confirmed in independent studies, suggests GDF5 plays a role in protecting heart cells from chemotherapy damage.

Area of Science:

  • Genetics
  • Cardiology
  • Pharmacology

Background:

  • Anthracyclines are vital chemotherapy drugs, but their use is limited by cardiotoxicity (ACT).
  • Previous genome-wide association studies (GWAS) identified genetic links to ACT, but require further investigation.
  • Understanding genetic predispositions to ACT is crucial for improving cancer patient outcomes.

Purpose of the Study:

  • To identify gene expression associations with anthracycline-induced cardiotoxicity (ACT) using transcriptome-wide association study (TWAS).
  • To validate the role of identified genes in ACT development and cardiac myocyte response to anthracyclines.

Main Methods:

  • Conducted a transcriptome-wide association study (TWAS) utilizing prior GWAS summary statistics from 280 patients.
  • Replicated key findings in an independent cohort of 845 patients.
  • Performed gene set enrichment and pathway analyses on TWAS data.
  • Assessed the impact of GDF5 gene silencing on human cardiac myocyte viability under anthracycline treatment.

Main Results:

  • Identified a significant association between decreased GDF5 gene expression and ACT (P = 1.70 × 10⁻⁵), replicated in an independent cohort (P = 3.54 × 10⁻³).
  • GDF5-silenced human cardiac myocytes exhibited reduced viability upon anthracycline exposure.
  • TWAS data highlighted the importance of survival, cardioprotection, anthracycline response, ribosomal, spliceosomal, and cardiomyopathy pathways in ACT development.

Conclusions:

  • Decreased GDF5 expression is a significant genetic factor associated with anthracycline-induced cardiotoxicity.
  • GDF5 plays a protective role in cardiac myocytes against anthracycline-induced damage.
  • Genetic pathways related to cellular survival, ribosome function, and cardiomyopathy are implicated in ACT pathogenesis.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.5K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
14.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.5K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
176
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
114